Lavipharm S.A. (ATH: LAVI)
Greece
· Delayed Price · Currency is EUR 0.723
+0.003 (0.42%)
Nov 20, 2024, 5:11 PM EET
Lavipharm Revenue
Lavipharm had revenue of 13.14M EUR in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 51.34M, up 17.35% year-over-year. In the year 2023, Lavipharm had annual revenue of 50.93M with 30.40% growth.
Revenue (ttm)
51.34M
Revenue Growth
+17.35%
P/S Ratio
2.36
Revenue / Employee
171.15K
Employees
307
Market Cap
121.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 50.93M | 11.87M | 30.40% |
| Dec 31, 2022 | 39.06M | -667.00K | -1.68% |
| Dec 31, 2021 | 39.72M | 2.09M | 5.54% |
| Dec 31, 2020 | 37.64M | 4.05M | 12.06% |
| Dec 31, 2019 | 33.59M | -470.00K | -1.38% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Athens Medical C.S.A. | 258.36M |
| Eurobank Ergasias Services and Holdings S.A. | 2.84B |
| National Bank of Greece S.A. | 2.80B |
| Hellenic Telecommunications Organization S.A. | 3.62B |
| Piraeus Financial Holdings S.A. | 2.73B |
| Metlen Energy & Metals S.A. | 5.46B |
| Public Power Corporation S.A. | 8.75B |